Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihua Yu

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Biological Chemistry|November 4, 2011
Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16Brian F Pickering, Dihua Yu, Michael W Van Dyke
Biochemical and Biophysical Research Communications|April 18, 2009
14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytesKristina Kligys, Jun Yao, Dihua Yu, et al.
Cancer Biology & Therapy|February 19, 2015
PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibitionSamuel W Brady, Jian Zhang, Ming-Horng Tsai, et al.
Nature Reviews. Clinical Oncology|December 23, 2009
Molecular predictors of response to trastuzumab and lapatinib in breast cancerFrancisco J Esteva, Dihua Yu, Mien-Chie Hung, et al.
Molecular Cancer Therapeutics|November 20, 2013
Enhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitorSamuel W Brady, Jian Zhang, Daniel Seok, et al.
Plos One|June 21, 2011
Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cellsAnupam Kumar, Hui Gao, Jia Xu, et al.
Nature Clinical Practice. Oncology|May 10, 2006
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancerRita Nahta, Dihua Yu, Mien-Chie Hung, et al.
Plos One|June 8, 2011
Cancer cell migration: integrated roles of matrix mechanics and transforming potentialErin L Baker, Jaya Srivastava, Dihua Yu, et al.
Biophysical Journal|October 7, 2010
Cancer cell stiffness: integrated roles of three-dimensional matrix stiffness and transforming potentialErin L Baker, Jing Lu, Dihua Yu, et al.
Cancer|July 13, 2002
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinomaWentao Yang, Kristine Klos, Ying Yang, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|November 4, 2011
Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16Brian F Pickering, Dihua Yu, Michael W Van Dyke
Biochemical and Biophysical Research Communications|April 18, 2009
14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytesKristina Kligys, Jun Yao, Dihua Yu, et al.
Cancer Biology & Therapy|February 19, 2015
PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibitionSamuel W Brady, Jian Zhang, Ming-Horng Tsai, et al.
Nature Reviews. Clinical Oncology|December 23, 2009
Molecular predictors of response to trastuzumab and lapatinib in breast cancerFrancisco J Esteva, Dihua Yu, Mien-Chie Hung, et al.
Molecular Cancer Therapeutics|November 20, 2013
Enhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitorSamuel W Brady, Jian Zhang, Daniel Seok, et al.
Plos One|June 21, 2011
Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cellsAnupam Kumar, Hui Gao, Jia Xu, et al.
Nature Clinical Practice. Oncology|May 10, 2006
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancerRita Nahta, Dihua Yu, Mien-Chie Hung, et al.
Plos One|June 8, 2011
Cancer cell migration: integrated roles of matrix mechanics and transforming potentialErin L Baker, Jaya Srivastava, Dihua Yu, et al.
Biophysical Journal|October 7, 2010
Cancer cell stiffness: integrated roles of three-dimensional matrix stiffness and transforming potentialErin L Baker, Jing Lu, Dihua Yu, et al.
Cancer|July 13, 2002
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinomaWentao Yang, Kristine Klos, Ying Yang, et al.
Pageof 16